|

Empirical Anatomy-Based Ablation vs Emphasize Map-Guided Substrate Ablation in Persistent Atrial Fibrillation : (COMPASS-AF)

RECRUITINGN/ASponsored by Samsung Medical Center
Actively Recruiting
PhaseN/A
SponsorSamsung Medical Center
Started2026-05-19
Est. completion2030-12-31
Eligibility
Age19 Years+
Healthy vol.Accepted

Summary

This study is aimed to compare the clinical efficacy of two different catheter ablation strategies in patients with persistent atrial fibrillation. Participants will be randomized 1:1 into either the Anatomy-based group or the Emphasize map-guided group * Anatomy-based group : Pulmonary vein isolation (PVI) using pulsed-field ablation (PFA) with a single-shot multielectrode catheter. * Emphasize map-guided group : PVI using radiofrequency (RF) ablation followed by additional EnSite X-guided pathologic substrate modification. Participants will be followed for 1 year to compare the incidence of any atrial tachyarrhythmia and other clinical parameters between the two groups.

Eligibility

Age: 19 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adults aged 19 years or older who have voluntarily provided written informed consent to participate in the study
* Patients diagnosed with persistent atrial fibrillation (AF) who are scheduled to undergo catheter ablation for AF.

Exclusion Criteria:

* History of prior catheter ablation or MAZE surgery for atrial fibrillation.
* Left atrial (LA) diameter exceeding 60 mm.
* Patients with end-stage renal disease (ESRD).
* History of prior open-heart surgery.
* Women who are pregnant, lactating, or of childbearing potential.
* Heart failure corresponding to New York Heart Association (NYHA) functional class IV.
* Acute coronary syndrome (ACS) experienced within the past 3 months.
* Patients with terminal illness and a life expectancy of less than one year.
* Any other condition that the investigator deems inappropriate for participation in the study.

Conditions2

Atrial Fibrillation (AF)Heart Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.